Clarity Medical Group Holding Limited announced Mr. Wong Tai Cheung Andrew has resigned as an executive Director and Authorised Representative and has ceased to act as the CEO. As it takes time to recruit the appropriate personnel, the Board has resolved to appoint Mr. Hui Yung Chris as the Authorised Representative and the CEO and has been re-designated from an independent non-executive Director to an executive Director and ceased to act as a member of each of the Audit Committee and the Remuneration Committee. To fill the vacancy of the independent non-executive Director, Professor Lau Wan Yee Joseph has been appointed as an independent non-executive Director and a member of each of the Audit Committee and the Remuneration Committee.

With these changes, the Board is of the view that, after the departure of Mr. Wong Tai Cheung Andrew who had joined the Group for more than five years, the Group shall appoint a candidate who has extensive experience in the provision of private ophthalmic services to oversee the operation and facilitate the future development of the Group and as such the Board has invited Dr. Tse Wai Ip to join the Board as an executive Director. Dr. Tse, aged 53, is the founder of the Group. Dr. Tse has accumulated over 20 years of medical practising experience.

Dr. Tse graduated from the Chinese University of Hong Kong with a degree of bachelor of medicine and bachelor of surgery (M.B., Ch.B.) in December 1993. Dr. Tse became a fellow of the Royal College of Surgeons of Edinburgh in June 1999, a fellow of the Hong Kong Academy of Medicine in the specialty of Ophthalmology in December 2002 and a fellow of the College of Ophthalmologists of Hong Kong in May 2003, respectively. Upon his graduationfrom the Chinese University of Hong Kong, Dr. Tse had been employed by the Hospital Authority as a house officer in 1994, and a medical officer from January 1995 to November 2003 and became a private practice ophthalmologist thereafter.

Dr. Tse founded the Group in August 2005 and has been practising as an ophthalmologist for the Group until October 2019 where he left the Group due to health conditions. He rejoined the Group in April 2022 as a medical practitioner. He has been a Registered Medical Practitioner in Hong Kong since August 1995 and a specialist in ophthalmology in Hong Kong since April 2003.

Dr. Tse obtained a qualification licence for his medical profession in the PRC in December 2013 and registered his place of practising and his scope of profession with the public health administrative authority of the PRC in January 2014. Dr. Tse is also pursuing a Doctor of Public Health degree from Johns Hopkins University. Mr. Hui, aged 53, joined Group on 29 March 2022 and had been appointed as an independent non-executive Director on the same day.

He obtained a bachelor's degree in Business Administration from the Chinese University of Hong Kong in July 1991. He has more than 22 years of experience in investment and capital markets. He is currently the executive director of Hong Kong Taikuk (China) Group Limited.

He has served as an external supervisor for China Bohai Bank Co. Ltd. since December 2019. He served as the secretary of the board of directors of Wanda Commercial Properties Company Limited from September 2015 to February 2019.

He also served as a non-executive director of Wanda Hotel Development Company Limited, which is a subsidiary of WCP and is listed on the Main Board of the Stock Exchange, from November 2017 to February 2019. Prior to joining WCP, Mr. Hui served as a founding partner of J&Partners GP Limited from December 2011 to September 2015. From July 2001 to July 2010, he worked at Barclays Investment Bank where he served as a managing director of Investment Banking Division.

He also served as a director of New China Trust Co. Ltd. from November 2009 to October 2010, a director of Deutsche Bank and head of multinational corporations and department of structural finance products in Asia Pacific from March 1996 to July 2001, and a vice president of the Debt Markets of Merrill Lynch (Asia Pacific) Limited from May 1994 to February 1996. Professor Lau, aged 75, an expert on hepato-pancreato-biliary surgery and an academician of the Chinese Academy of Sciences, is the founding master of Lee Woo Sing College and Research Professor at the Faculty of Medicine and Emeritus Professor at the Department of Surgery of The Chinese University of Hong Kong, current chairman of the Medical Council of Hong Kong, past president of the International Hepato-Pancreato-Biliary Association and Asian-Pacific Hepato-Pancreato-Biliary Association.

Professor Lau obtained bachelor's degrees in medicine and surgery from the University of Hong Kong in Hong Kong in 1972 and was conferred a degree of doctor of medicine from the Chinese University of Hong Kong in Hong Kong in December 1995. Professor Lau has been an independent non-executive director of NISI (HK) Limited, a company that specializes in noninvasive surgical innovations, since February 2017. Professor Lau has also been an independent non-executive director of Venus Medtech (Hangzhou) Inc. since December 2019 and an independent non-executive director of Broncus Holdings Corporation since September 2021.

Professor Lau is active both at the international and local surgical scene and holds many key positions in government and professional organizations. He has been the chairman of the Medical Council of Hong Kong since March 2012. He was president of the International Hepato-Pancreato-Biliary Association from April 2002 to 2004.

He was elected as an academician of the Chinese Academy of Sciences in 2003, and was awarded Honorary Fellow of Royal Australasian College of Surgeons in October 2003. He was president of Asian-Pacific Hepato-Pancreato-Biliary Association from 2009 to 2011, and was awarded Honorary Fellow of College of Surgeons of Hong Kong in 2011.